Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 603,500 | 433,900 | 228,300 | 419,200 | 586,000 |
| Depreciation Amortization | 472,900 | 311,400 | 154,500 | 577,300 | 446,100 |
| Income taxes - deferred | -58,600 | -39,100 | -19,500 | -78,100 | -18,200 |
| Accounts receivable | -120,400 | -165,400 | -123,200 | -75,300 | -70,200 |
| Accounts payable and accrued liabilities | -138,200 | -51,700 | -121,100 | -42,400 | -188,600 |
| Other Working Capital | -437,800 | -365,000 | -471,300 | -361,900 | -586,500 |
| Other Operating Activity | 487,200 | 407,200 | 322,500 | 888,900 | 579,500 |
| Operating Cash Flow | $808,600 | $531,300 | $-29,800 | $1,327,700 | $748,100 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -22,300 | N/A |
| PPE Investments | -377,200 | -261,800 | -133,700 | -453,000 | -286,100 |
| Net Acquisitions | -737,700 | -279,600 | -245,700 | -671,500 | -516,700 |
| Purchase Of Investment | -42,300 | -36,700 | -13,700 | N/A | -20,100 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 6,700 |
| Other Investing Activity | 0 | 0 | 0 | -24,700 | -24,700 |
| Investing Cash Flow | $-1,157,200 | $-578,100 | $-393,100 | $-1,171,500 | $-840,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,463,700 | 951,900 | 253,200 | 2,488,200 | 1,968,500 |
| Debt Repayment | -3,063,700 | -932,100 | -210,800 | -2,788,200 | -1,878,900 |
| Common Stock Issued | 53,000 | 26,700 | 26,700 | 54,400 | 54,400 |
| Common Stock Repurchased | -175,000 | -100,000 | N/A | -1,000,000 | -1,009,000 |
| Dividend Paid | -183,000 | -122,500 | -62,100 | -254,000 | -192,900 |
| Other Financing Activity | 231,600 | -45,700 | -18,700 | 1,440,300 | 1,445,100 |
| Financing Cash Flow | $1,326,600 | $-221,700 | $-11,700 | $-59,300 | $387,200 |
| Exchange Rate Effect | 2,500 | -3,200 | -2,900 | 9,900 | 3,500 |
| Beginning Cash Position | 536,800 | 536,800 | 536,800 | 430,000 | 430,000 |
| End Cash Position | 1,517,300 | 265,100 | 99,300 | 536,800 | 727,900 |
| Net Cash Flow | $980,500 | $-271,700 | $-437,500 | $106,800 | $297,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 808,600 | 531,300 | -29,800 | 1,327,700 | 748,100 |
| Capital Expenditure | -377,800 | -262,000 | -133,800 | -453,600 | -286,400 |
| Free Cash Flow | 430,800 | 269,300 | -163,600 | 874,100 | 461,700 |